DOPATREE
Preview
Open in TheBrain
DOPATREE
ORGANIZATIONS
GOVERNMENT ORGANIZATIONS-ALL (GOVT, GOV’T)
UNITED STATES GOVERNMENT ORGANIZATIONS / LISTINGS
US FOOD AND DRUG ADMINISTRATION (FDA)
DRUGS AND BIOLOGICS / RELATED / US
US FDA NEW MOLECULAR ENTITY APPROVALS (NME, NEW CHEMICAL ENTITIES, NBE, NEW BIOLOGICAL ENTITIES)
US FDA NEW MOLECULAR ENTITY APPROVALS / LISTINGS / 2019
SIPONIMOD (MAYZENT®)
SIPONIMOD / MARKET ACCESS
Parents
SIPONIMOD (MAYZENT®)
Children
ICER. MULTIPLE SCLEROSIS : CIS, RRMS, AND SPMS. AN ASSESSMENT OF ORAL AND MONOCLONAL ANTIBODY TREATMENTS FOR RELAPSING FORMS OF MS. PUBLIC MEETING : JAN 2023.
ICER. MULTIPLE SCLEROSIS : SPMS. AN ASSESSMENT OF SIPONIMOD FOR THE TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS. PUBLIC MEETING. MAY 2019.